David Stone 11/23/21 David Stone 11/23/21 Gilead and the NIH Appear to be Holding Back Data on LNC Remdesivir Read More David Stone 11/14/21 David Stone 11/14/21 Demand for Covid-19 Antivirals Will Exceed Supply Read More David Stone 10/1/21 David Stone 10/1/21 Merck’s Covid Pill Reduces Hospitalization by About 50% Read More David Stone 9/22/21 David Stone 9/22/21 Early Use of Remdesivir Reduces Hospitalization by 87% Read More David Stone 9/17/21 David Stone 9/17/21 The Market Potential of Oral Remdesivir Read More
David Stone 11/23/21 David Stone 11/23/21 Gilead and the NIH Appear to be Holding Back Data on LNC Remdesivir Read More
David Stone 11/14/21 David Stone 11/14/21 Demand for Covid-19 Antivirals Will Exceed Supply Read More
David Stone 10/1/21 David Stone 10/1/21 Merck’s Covid Pill Reduces Hospitalization by About 50% Read More
David Stone 9/22/21 David Stone 9/22/21 Early Use of Remdesivir Reduces Hospitalization by 87% Read More